.png){kind=icon}
.png){kind=icon}
Return
DNAemia Thresholds to Discontinue Antivirals in Preemptive Management for Cytomegalovirus Seropositive Recipients After Kidney Transplantation
.png){kind=icon}
PRE
AI
M
F
T
J
R
DOI：10.1097/TP.0000000000005695.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Treatment of cytomegalovirus (CMV) after kidney transplantation aims to achieve cessation of viral replication; however, the use of highly sensitive DNA assays creates uncertainty regarding the optimal DNAemia threshold for safely discontinuing antiviral therapy. We evaluated the safety and efficacy of ending antiviral therapy at a lower DNAemia cutoff (<log10 2.30; 200 IU/mL), compared with undetectable DNAemia (<log10 1.49; 31 IU/mL).
Journal
IF:
5
Papers:
2.8W
Citations:
2.3W
Organization
Cited Papers